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Abstract 
We have investigated differences in C*pG methylation between F9 embryonal carcinoma cells in vitro and 
as tumor cells grown in vivo using Msp I and Hpa II restriction isoschizomers. Southerns were hybridized 
with two low copy number probes, mouse major/3-globin (f7) and a class I, histocompatibility-2 cDNA clone 
(pH-2d-4). In each case, the tumor -DNA was hypomethylated while the DNA from F9 cells grown in vitro 
was moderately methylated. We conclude that growth conditions or cell-cell interactions can greatly affect 
methylation of C*pG sites. 
Introduction 
Many studies of site-specific methylation of 
structural genes have found hypomethylation of 
variably methylated sites in tissues or cells where 
the gene is expressed (16, 19, 21, 26, 27, 32) and 
hypermethylation in tissues where they are not ex- 
pressed. Whether DNA methylation plays a role in 
the control of gene expression or if methylation 
occurs after regulation cannot be presently ascer- 
tained. In point of fact, many exceptions to this 
correlation have been found (9, 10, 18, 24, 35). 
One of the exceptions to the degree of methyla- 
tion of certain genes is that which occurs in trans- 
formed cells and tissues. Analysis of DNA from 
lung and colon tumors, with three specific probes to 
genes not expressed in these tumors, showed them 
to be hypomethylated when compared to their 
normal tissue counterparts (6). Because these tu- 
mors had not been adapted to tissue culture and were 
from untreated patients, hypomethylation of nor- 
mally hypermethylated genes cannot be due to an 
experimental manipulation. In one case, several 
metastases were found to have increasingly hypo- 
methylated patterns compared to the primary tu- 
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mot. I n contrast, a comparison of methylated C* pG 
sites in adult rat liver, a rat hepatoma line, and fetal 
rat liver using probes to albumin and alpha fetal 
protein genes showed no correlation in the changes 
in the methylation pattern with gene activation or 
repression (24). These data suggest that (l) the rap- 
id growth of tissues affects the methylation pattern 
of various genes; (2) the relationship of cell-cell 
interactions in culture versus tumors of various 
tissues affect the degree of methylation; or (3) the 
morphology and state of differentiation of tumors 
change in comparison to their normal counterpart  
during tumorgenesis and metastasis. 
We have investigated the first and second possi- 
bility, i.e., that growth and /o r  cell-cell interactions 
may influence methylation patterns in tissues and 
cells from tumors using embryonal carcinoma cells. 
In order to control for possible differences in differ- 
entiated and undifferentiated tissues, we used the 
F9 mouse embryonal carcinoma (EC) line. F9 is a 
'nullipotent '  EC cell line originally derived from a 
transplantable testicular tumor that arose in strain 
129/J (1). Although considered 'nullipotent' ,  
treatment with trans-retinoic acid will stimulate 
almost all of the cells to differentiate to primitive 
llO 
yolk sac cells (33). F9 EC cells grown subcutaneous- 
ly in syngeneic hosts grow rapidly, forming well-de- 
fined tumor masses with only embryonal-like cells 
apparent. 
We recently used F9 tumor DNA as a control 
during studies of DNA methylation during sperma- 
togenesis (25) and found it to be hypomethylated 
when Southerns were probed with several cDNA 
clones, including to H-2. Unlike many other tu- 
mors, EC cells or tumors do not normally express 
class I histocompatibility antigens (2), H-2, unless 
differentiated (31) or transplanted to non-syngeneic 
hosts (23). In contrast, Morello et al. (22) bad found 
a high degree of methylation of C*pG site at the H-2 
locus in cultured F9 cells. In this study we com- 
pared the degree of methylation of F9 cells when 
grown in vitro and in vivo, using restriction iso- 
schizomers. We present data herein that F9 nullipo- 
tent embryonal carcinoma cells are hypermethylat- 
ed when grown in tissue culture, but hypomethylat- 
ed when grown in vivo. Thus, growth conditions are 
likely to be an explanation for the variable methyla- 
tion. 
Materials and methods  
F9 EC cellular DNA was obtained from cultures 
grown in Ann Arbor and Paris. The Ann Arbor 
cells, originally obtained from Dr. Peter Andrews, 
were grown in D-MEM (Gibco) containing anti- 
biotics (penicillin and streptomycin) and 5% heat 
inactivated fetal calf serum. Cells were trypsinized 
and replated every three days to avoid accumulat- 
ing spontaneously differentiating cells. The F9 and 
related PCC4/Aza  cellular DNA from Paris was 
obtained as previously described (22). F9 tumors 
were induced by injecting approximately 1 • 105 F9 
cells (Ann Arbor) subcutaneously into 129/SvJ 
male mice. Tumors were taken when less than 1 cm 
in diameter; they were found to be typical of undif- 
ferentiated embryonal  carcinomas in vivo. DNA 
was purified from .both tumors and cells using the 
proteinase K/phenol  method (1 l). 
Restriction digests with Eco RI, Msp I, and Hpa 
II were performed as recommended by the manu- 
facturer (Bethesda Research Laboratories and PL 
Biochemicals) using twice the recommended con- 
centration for24 hrs at 37 ~ The DNA was ethanol 
precipitated and resuspended in TE buffer and 
tracking dye. Electrophoresis was carried out in 1% 
agarose (BRL) at constant voltage (1.6 V/cm) in 'E '  
buffer as previously described (25). Transfer of 
DNA to nitrocellulose or Gene Screen | was per- 
formed as described by Southern (30). Hybridiza- 
tions were performed at 42 ~ in 5XSSC and 35% 
formamide. 
Low copy number probes 
The specific gene probes used were a mouse/3- 
major globin clone, f7, [Dr. Carolyn Jahn, (14)], 
and a mouse class 1, histocompatibility-2 clone, 
pH-2U-4, [Dr. Gabriel Gachelin, (15)]. Nick transla- 
tions of the probes were done with the NEK-004C 
kit of New England Nuclear using [a32p]-dCTP at 
400 mCi /mM.  Any one figure represents strips hy- 
bridized with the same probe and exposed for the 
same length of time. 
Results  and discussion 
Hybridization of Msp I and Hpa 11 restricted 
DNA from F9 tumor  and cells with the mouse 
major/3-globin probe showed the tumor DNA to be 
less methylated at C*pG sites (Fig. 1). The Hpa lI 
pattern of F9 tumor  DNA was nearly identical to 
that found after restriction with Msp l, differing by 
the presence of a 7.7 kb fragment with Hpa II not 
seen with Msp I. A previously prepared batch of F9 
tumor DNA studied by these methods and with this 
probe had shown identical Hpa II and Msp 1 pat- 
terns (25). Thus, it is probable that there exists vari- 
ability in the degree of C*pG methylation of DNA 
extracted from different F9 tumors similar to that 
existing between different F9 in vitro lines. F9 cell 
line DNA (Ann Arbor) showed Hpa I1 fragments of 
13.5 and 7.7 kb and less of the 6.0 and 2.7 kb 
fragments seen in the Msp 1 digestion. The F9 cell 
line from Paris seemed even more methylated as 
only the 6 kb, and fainter higher M.W. bands, were 
seen with Hpa II digestion. All three DNA prepara- 
tions showed similar Eco R! restriction patterns. 
A similar result was found when the DNAs were 
probed with the class I, major histocompatibility 
complex cDNA clone, pH-2d-4 (Fig. 2). The F9 
tumor showed nearly identical Msp I and Hpa I1 
digestion patterns while F9, and PCC4 (a multipo- 
tent embryonal carcinoma cell line), showed varia- 
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Fig. 1. Hybridization of,8-major globin probe (f7) to Eco RI (E), 
Hpa 11 (H) and Msp 1 (M) restricted DNA from F9 tumor DNA 
(left three lanes), F9-Ann Arbor cellular DNA (middle three 
lanes) and F9-Paris cellular DNA (right three lanes). 
Fig. 2. Hybridization of H-2 complex probe (pH-2a-4) to Eco R I 
(E), Hpa 11 (H) and Msp I (M) restricted DNA. DNAs were 
obtained from F9 tumors (set 1), F9-Ann Arbor cellular DNA 
(set 2), F9-Paris cellular DNA (set 3), and PCC4, Aza cellular 
DNA (Paris, set 4). 
ble degrees of  C*pG methyla t ion .  The Ann  A r b o r  
F9 cell line showed the least difference between 
Msp I and Hpa II d iges t ions  while the Paris  F9 cell 
line was m a r k e d l y  res is tant  to Hpa II d iges t ion  and 
only showed the 7.3 Hpa II band and smears  of 
hybr id i za t ion  f rom 3 12 kb. The PCC4 line hybr id-  
ized poor ly  af ter  Msp I and Hpa II d iges t ions  but  
the hybr id iza t ion  which occurred was at higher 
M.W. ' s  with Hpa l l .  Al l  four  D N A  PrePara t ions  
gave s imilar  Eco RI res t r ic t ion pat terns.  
It has been pos tu la ted  that  decreased C*pG 
methy la t ion  is cor re la ted  with al tered gene expres-  
sion and lack of no rma l  growth  cont ro ls  in malig-  
nant  tissue. Measurement s  of  to ta l  5 -methylcy to-  
sine by high pe r fo rmance  liquid c h r o m a t o g r a p h y  in 
a large var ie ty  of  t umors  also revealed a cor re la t ion  
of  mal ignancy  with decreased 5-methylcytos ine  
content  (7) and hybr id iza t ions  with unique se- 
quence probes  to unexpressed  genes conf i rmed  this 
(6). Azacy t id ine  can induce tumor igenes is  of  cul- 
tured  cell lines at the same t ime that  it results in 
D N A  hypome thy l a t i on  and c h r o m o s o m e  changes 
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(13). However ,  these cor re la t ions  might  be causal ly  
unre la ted  and the hypome thy l a t i on  might  be sec- 
onda ry  to some aspect  of mal ignancy,  such as high 
growth  rate. Our  results show that  a par t icular ,  
homogeneous  cell line, F9 embryona l  ca rc inoma,  is 
less methyla ted  at two unexpressed sequences when 
grown in vivo (p resumed  op t ima l  g rowth  condi -  
t ions) than  in vitro. The da ta  are most  easily inter-  
pre ted  as showing that  a l tered growth  condi t ions  
are responsible  for the difference. 
It has been observed that  subclones of  one cell 
line show large differences in methyla t ion ,  whether  
s tudied in terms of  C*pG methy la t ion  of  to ta l  D N A  
(29) (by densi ty scanning e lec t rophore tograms  of  
res t r ic ted D N A )  or  for pa r t i cu la r  unique sequences 
(28). Our  da ta  suggest that  there  may be differences 
in C*pG methy la t ion  between F9 cells grown in 
Par is  and  those  grown in Ann  A r b o r  but  genetic 
drift  (the cell lines have been separa ted  for several  
hundred  generat ions)  or slight differences in cul ture 
technique  may be responsible .  Whi le  select ion for  
expressed genes may al ter  D N A  methy la t ion  of  
those genes (12), our  use of  p robes  for  genes which 
are unexpressed  in vitro or in vivo makes it unl ikely 
that  selective changes were invoked in the differing 
degrees of D N A  methyla t ion.  
Our  results  seem to be in confl ic t  with those  
recently repor ted  by T a n a k a  et al. (34) who found 
an assoc ia t ion  of  hype rme thy la t ion  of  a class I, 
h i s tocompat ib i l i ty  gene and its express ion in F9 
cells. As stated in the In t roduc t ion  F9 cells do not  
no rma l ly  express  H-2 antigens;  T a n a k a  et al. (34) 
s tudied unusua l  cell lines. Dif ferent ia ted  clones of  
F9 were selected af ter  re t inoic  acid t rea tment  which 
express  H-2 ant igens (6 months  t rea tment  was ne- 
cessary to find a line with amoun t s  of  H-2 typical  
for  splenocytes)  and  these were used by these au-  
thors.  Since the conclus ions  of  T a n a k a  et al. (34) 
are based on the compa r i son  of  several derived lines 
differing in H-2 expression,  the unusual  direct  
cor re la t ion  of  H-2 express ion with several C*pG 
methy la t ion  sites they found  may be an ar t i fact  of  
divergence in me thy la t ion  between long separa ted  
cell lines which is unre la ted  to the gene expression.  
Al ternat ively ,  the sites they have s tudied may not  
have been detected in our  study.  
Whi le  differences in C*pG methy la t ion  found 
between ma l ignan t  and norma l  cells may be related 
to var iables  such as g rowth  rate  ra ther  than  to 
genetic cont ro l ,  deta i led studies of  D N A  methyla-  
t ion in the g lob in  system suggest  the poss ibi l i ty  of  a 
role for  C*pG methyla t ion  in cont ro l  of  t ranscr ip-  
t ion of  some genes. Many  studies (5, 16, 20, 27, 35) 
have consis tent ly  found decreased methy la t ion  of  
expressed g lobin  genes. It is now becoming  appa r -  
ent that  the sites whose methy la t ion  is most corre-  
lated with t ranscr ip t ion  are near  the 5' end of  the 
g lobin  genes (4). On the o ther  hand,  methy la t ion  
had no effect on the t r ansc r ip t ion  of  X e n o p u s  glo- 
bin genes injected into X e n o p u s  oocytes  (3), or on the 
t r ansc r ip t ion  of  r ibosomal  genes (17). Thus,  even in 
the case of  g lobin  genes, the cor re la t ion  may be 
secondary  ra ther  than causal.  
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